1. Home
  2. AGIO vs CENTA Comparison

AGIO vs CENTA Comparison

Compare AGIO & CENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$28.08

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Central Garden & Pet Company Nonvoting

CENTA

Central Garden & Pet Company Nonvoting

HOLD

Current Price

$34.74

Market Cap

2.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIO
CENTA
Founded
2007
1955
Country
United States
United States
Employees
N/A
6000
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
AGIO
CENTA
Price
$28.08
$34.74
Analyst Decision
Buy
Hold
Analyst Count
8
4
Target Price
$38.88
$36.75
AVG Volume (30 Days)
856.8K
277.1K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,011,000.00
N/A
Revenue This Year
$76.75
$1.60
Revenue Next Year
$170.73
$2.04
P/E Ratio
N/A
$13.52
Revenue Growth
N/A
N/A
52 Week Low
$22.24
$25.97
52 Week High
$46.00
$37.71

Technical Indicators

Market Signals
Indicator
AGIO
CENTA
Relative Strength Index (RSI) 48.55 56.83
Support Level $26.42 $30.98
Resistance Level $29.37 $35.14
Average True Range (ATR) 0.94 1.18
MACD 0.16 0.03
Stochastic Oscillator 64.79 40.81

Price Performance

Historical Comparison
AGIO
CENTA

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

About CENTA Central Garden & Pet Company Nonvoting

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

Share on Social Networks: